A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
Clinical trial NCT06199089 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06199089
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-16
- Primary completion
- 2024-11-28
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.